Algorithms for characterizing brain metabolites in two-dimensional in vivo MR correlation spectroscopy

Traditional analyses of in vivo 1D MR spectroscopy of brain metabolites have been limited to the inspection of one-dimensional free induction decay (FID) signals from which only a limited number of metabolites are clearly observable. In this article we introduce a novel set of algorithms to process and characterize two-dimensional in vivo MR correlation spectroscopy (2D COSY) signals. 2D COSY data was collected from phantom solutions of topical metabolites found in the brain, namely glutamine, glutamate, and creatine. A statistical peak-detection and object segmentation algorithm is adapted for 2D COSY signals and applied to phantom solutions containing varied concentrations of glutamine and glutamate. Additionally, quantitative features are derived from peak and object structures, and we show that these measures are correlated with known phantom metabolite concentrations. These results are encouraging for future studies focusing on neurological disorders that induce subtle changes in brain metabolite concentrations and for which accurate quantitation is important.

[1]  Kristin H. Jarman,et al.  A new approach to automated peak detection , 2003 .

[2]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[3]  Yvonne Tran,et al.  Neuro magnetic resonance spectroscopy using wavelet decomposition and statistical testing identifies biochemical changes in people with spinal cord injury and pain , 2010, NeuroImage.

[4]  A. Sorensen,et al.  Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma. , 2011, Radiology.

[5]  Alan Willse,et al.  Identification of major histocompatibility complex-regulated body odorants by statistical analysis of a comparative gas chromatography/mass spectrometry experiment. , 2005, Analytical chemistry.

[6]  Peter Boesiger,et al.  ProFit: two‐dimensional prior‐knowledge fitting of J‐resolved spectra , 2006, NMR in biomedicine.

[7]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[8]  J. Sorenson,et al.  Localized 2D J-resolved 1H MR spectroscopy: strong coupling effects in vitro and in vivo. , 1995, Magnetic resonance imaging.

[9]  Saadallah Ramadan,et al.  Neurospectroscopy: the past, present and future. , 2010, Chemical reviews.

[10]  Localized 2D correlation spectroscopy in human brain at 3 T , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.

[11]  S. Bluml,et al.  Efficacy of Proton Magnetic Resonance Spectroscopy Inclinical Decision Making for Patients with Suspected Malignant Brain Tumors , 2004, Journal of Neuro-Oncology.

[12]  Meng Law,et al.  Proton MR spectroscopy of tumefactive demyelinating lesions. , 2002, AJNR. American journal of neuroradiology.

[13]  R. Lenkinski,et al.  A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. , 2006, AJNR. American journal of neuroradiology.

[14]  R Lufkin,et al.  Localized two‐dimensional shift correlated MR spectroscopy of human brain , 2001, Magnetic resonance in medicine.

[15]  Clifford R. Jack,et al.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease , 2004 .

[16]  C. Mountford,et al.  Chapter 6 Two‐Dimensional Magnetic Resonance Spectroscopy on Biopsy and In Vivo , 2009 .